Overview


According to FutureWise analysis, the market for Ribonucleic Acid (RNA) Markers is expected to grow with a CAGR of 8.76% over the forecast period 2024-2032, and reach a market value of US$ 0.43 Billion by 2031. 

Ribonucleic Acid (RNA) markers represent a critical facet of molecular biology and genomics research, playing a pivotal role in elucidating genetic information and unravelling various cellular processes. RNA, a single-stranded nucleic acid molecule, is central to the transcription and translation of genetic information from DNA into functional proteins, making it a dynamic and informative biomolecule. RNA markers refer to specific segments or sequences of RNA molecules that indicate particular genetic characteristics, biological functions, or disease states. These markers are instrumental in various applications across the life sciences. In genomics, they serve as invaluable indicators for understanding gene expression patterns. Through next-generation sequencing (NGS) and microarray analysis, researchers can scrutinize RNA marker profiles to gain insights into the activity levels of specific genes in different tissues, developmental stages, or disease conditions. This information is pivotal for deciphering the molecular underpinnings of diseases and identifying potential therapeutic targets.

Moreover, RNA markers play a crucial role in personalized medicine initiatives. By characterizing the RNA profiles of individual patients, clinicians can tailor treatment strategies to align with the unique genetic makeup of each person. This approach has proven particularly impactful in oncology, where specific RNA markers can inform treatment decisions by identifying targetable mutations or predicting treatment response.

FutureWise Market Research has published a report that provides an insightful analysis of Ribonucleic Acid (RNA) Markers Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Ribonucleic Acid (RNA) Markers Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Agilent Technologies, Inc.
  • Oxford Gene Technology IP Limited
  • PerkinElmer Inc.
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd
  • NextGen Life Sciences Private Limited
  • bioMérieux SA
  • New England Biolabs
  • Promega Corporation
  • Merck KGaA
  • Takara Bio Inc.
  • Abnova Corporation
  • Thermo Fisher Scientific Inc
  • QIAGEN
  • Bio-Rad Laboratories, Inc. 
  • Lonza, CardioNet
  • ZOLL Medical Corporation and Hill-Rom Services, Inc.
  • Hill-Rom Services, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Ribonucleic Acid (RNA) Markers Market:

  • Eurofins Discovery, a U.S.-based company specializing in drug discovery, completed the acquisition of DiscoveryBioMed, a contract research organization in life sciences and biotechnology, on July 5, 2022. This strategic move aligns with Eurofins Discovery's goal of expanding its drug discovery services and product portfolio.

Continuous advancements in molecular biology techniques have expanded the applications of RNA markers, driving their adoption in research, diagnostics, and drug development. The shift towards personalized medicine, which tailors treatments to individual patient characteristics, is driving the demand for RNA markers as they can provide valuable insights into specific molecular profiles. The increasing surge of chronic ailments like cancer and cardiovascular disorders necessitates using RNA markers for early detection, prognosis, and treatment response monitoring. RNA markers play a crucial role in target identification and validation and in assessing drug efficacy and safety during the drug development process. NGS technologies have significantly enhanced the ability to analyze RNA markers with higher throughput and accuracy, driving their adoption in research and clinical settings. Supportive government policies, grants, and funding programs for genomics and biomarker research contribute to the growth of the RNA markers market.

However, ensuring the standardization and validation of RNA markers across different laboratories and platforms can be complex, potentially leading to variability in results. The analysis and interpretation of RNA marker data, especially in the context of large-scale genomics studies, can be challenging and may require specialized bioinformatics expertise. Developing and validating RNA markers for specific applications can be resource-intensive, requiring significant investments in research and development and hence restraints the market.

By Type

  • Prestained Markers
  • Unstained Markers
  • Specialty Markers

By Application

  • Nucleic Acid Applications
  • Proteomics Applications

By End User

  • Research Centers
  • Pharmaceutical and Biotechnology Companies
  • Others (Academic Institutes, Forensic Laboratory and Others)

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to increasing research and development activities by the market players, robust healthcare infrastructure, and the prominent presence of key industry players in driving growth in this market. Conversely, the European region is poised for substantial expansion in the forecast period due to increasing investment in research and development and an escalating demand for high-quality healthcare services. 

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Ribonucleic Acid (Rna) Markers Market By Type, By Application, By End User, and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction

    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology

    •   1 Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3.Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary

    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Ribonucleic Acid (Rna) Markers Market Variables, Trends & Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview

    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Ribonucleic Acid (Rna) Markers Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Ribonucleic Acid (Rna) Markers Market Analysis Tools

    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Ribonucleic Acid (Rna) Markers Market, By Type Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Prestained Markers
      2. Unstained Markers
      3. Specialty Markers
         
  • 8.  Ribonucleic Acid (Rna) Markers Market, By Application Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Nucleic Acid Applications
      2. Proteomics Applications
         
  • 9.  Ribonucleic Acid (Rna) Markers Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Research Centers
      2. Pharmaceutical and Biotechnology Companies
      3. Others ( Academic Institutes, Forensic Laboratory and Others)
         
  • 10.  North America Ribonucleic Acid (Rna) Markers Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 11.  Latin America Ribonucleic Acid (Rna) Markers Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 12.  Europe Ribonucleic Acid (Rna) Markers Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 13.  Asia Pacific Ribonucleic Acid (Rna) Markers Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 14.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 15.  Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 16.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)

    •   1. Agilent Technologies, Inc
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. Oxford Gene Technology IP Limited
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. PerkinElmer Inc.
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Eurofins Scientific
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. F. Hoffmann-La Roche Ltd
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. NextGen Life Sciences Private Limited 
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. bioMérieux SA
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. New England Biolabs
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. Promega Corporation
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. Merck KGaA
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview
        11. Takara Bio Inc.
           11.1. Company Overview
           11.2. Product Portfolio
           11.3. SWOT Analysis
           11.4. Financial Overview
           11.5. Strategic Overview
        12. Abnova Corporation
           12.1. Company Overview
           12.2. Product Portfolio
           12.3. SWOT Analysis
           12.4. Financial Overview
           12.5. Strategic Overview
        13. Thermo Fisher Scientific Inc.
           13.1. Company Overview
           13.2. Product Portfolio
           13.3. SWOT Analysis
           13.4. Financial Overview
           13.5. Strategic Overview
        14. QIAGEN
           14.1. Company Overview
           14.2. Product Portfolio
           14.3. SWOT Analysis
           14.4. Financial Overview
           14.5. Strategic Overview
        15. Bio-Rad Laboratories, Inc.
           15.1. Company Overview
           15.2. Product Portfolio
           15.3. SWOT Analysis
           15.4. Financial Overview
           15.5. Strategic Overview
        16. Lonza, CardioNet
           16.1. Company Overview
           16.2. Product Portfolio
           16.3. SWOT Analysis
           16.4. Financial Overview
           16.5. Strategic Overview
        17. ZOLL Medical Corporation and Hill-Rom Services, Inc.
           17.1. Company Overview
           17.2. Product Portfolio
           17.3. SWOT Analysis
           17.4. Financial Overview
           17.5. Strategic Overview
        18. Hill-Rom Services, Inc.
           18.1. Company Overview
           18.2. Product Portfolio
           18.3. SWOT Analysis
           18.4. Financial Overview
           18.5. Strategic Overview

  • 17.  Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
            administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.  FutureWise SME Key Takeaway Points for Client

    •   


Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11